In this lecture series, professionals from industries, academia and patient organizations will share their visions how the patient perspective can become an integral part of the drug development process, and how this relates to public interests, regulatory requirements, the law and international initiatives.

Without voluntary participation of patients in clinical trials, development of new drugs would not be possible. Besides their participation in clinical trials, patients’ engagement is important for various stakeholders in drug development and render their efforts meaningful. Hence, the question is not if the patients’ perspectives should be put at the center of drug development but how?

We are pleased to present five renowned experts in the field who will share their initiatives and ideas when it comes to the patients’ voice in drug development.
The Department of Health Science and Health Policy is looking forward to welcoming all interested listeners.

Flyer Lecture Series Spring 2018

Poster Lecture Series Spring 2018

30th January 2018